Financial snapshot

The $25 bln Japanese company is offloading its historic but unprofitable imaging division 18 months after pushy investor ValueAct prompted a shakeup. A new focus on medical equipment has helped send Olympus shares soaring. The question now is whether expectations are too rosy.